NIH-funded research R01 grant

Understanding how certain mutations affect colon cancer development

Official title: Mechanisms of Serrated Colon Tumor Suppression

Funded at Rutgers, the State Univ of N.j. · NIH-11086702 · Data updated 2026-11-12

This study is looking at how certain changes in genes can lead to colon cancer by focusing on the early stages in colon stem cells, which could help us find better ways to spot and prevent this type of cancer in the future.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRutgers, the State Univ of N.j.
NIH-funded
Lab location1 site (Piscataway, United States)
Project startJune 8, 2023
Project endMay 31, 2028
Funding year2025
Award (this year)$392,500
NIH project number5R01CA190558-08
Project IDNIH-11086702 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with a family history of colon cancer or those identified as having genetic predispositions to Serrated tumors.

Less likely to help

Patients with non-Serrated forms of colon cancer or those without any genetic risk factors for colon cancer may not benefit from this research.

What this research studies

This research investigates the early mechanisms of colon cancer formation, specifically focusing on the effects of BRAF mutations in colon stem cells. By studying these mutations in a controlled environment, researchers aim to uncover how they influence tumor development and differentiation. The project will utilize advanced genetic mouse models to analyze the role of specific transcription factors and their impact on cancer susceptibility. This work could lead to improved strategies for early detection and prevention of Serrated colon tumors.

Why it matters

Potential benefit: If successful, this research could lead to better methods for detecting and preventing Serrated colon cancer in patients.

How similar studies have gone: Previous research has shown promising results in understanding the genetic factors involved in colon cancer, making this approach a continuation of established findings.

Where this research is happening

  • Rutgers, the State Univ of N.j.
    Piscataway, United States
    Active

Researchers

  • Principal investigator: Verzi, Michael P. — Rutgers, the State Univ of N.j.
  • Study coordinator: Verzi, Michael P.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.